Application no. and date | 10769052.1 (espacenet) (Federated) (European Patent Register), 20101025 | Patent/reg. no. and date | DK/EP 2493870, 20141217 | Publication date | 20120905 | Priority no. and date | EP 09306017, 20091027 | EP pub. no. and date |
EP 2493870 20120905 | Effective date | | Applicant/owner | AstraZeneca AB,
151 85 Södertälje, SE | Applicant ref. no. | Astra 103831-EP-EPT | Inventor | BARLAAM, Bernard, Christophe, AstraZeneca Pharma Z.I La Pompelle BP 1050
F-51689 Reims Cedex 2, FR, DEGORCE, Sebastien, Louis, AstraZeneca Pharma Z.I La Pompelle BP 1050
F-51689 Reims Cedex 2, FR, LAMBERT-VAN DER BREMPT, Christine, Marie, Paul, AstraZeneca Pharma Z.I La Pompelle BP 1050
F-51689 Reims Cedex 2, FR, MORGENTIN, Remy, Robert, AstraZeneca Pharma Z.I La Pompelle BP 1050
F-51689 Reims Cedex 2, FR, PLE, Patrick, AstraZeneca Pharma Z.I La Pompelle BP 1050
F-51689 Reims Cedex 2, FR | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 31/5377 (2006.01) , A61K 31/558 (2006.01) , C07D 311/22 (2006.01) | Title | CHROMENONDERIVATER MED ANTITUMORAKTIVITET | Int. application no. | GB2010051788 | Int. publication no. | WO2011051704 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|